Executive record

Joshua Bleharski

Chief Financial Officer at IDEAYA Biosciences, Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:joshua-bleharski-idyaVersion: public-0As of: 2026-09-30

Not yet claimed10 published Claims3 sources
  • Executive

Key Claims

Biography

Served as Managing Director and Global Co-Head of Biopharma within J.P. Morgan's Healthcare Investment Banking group for nearly 17 years, advising on deals representing more than $65 billion of value. Prior to banking, worked as a Senior Staff Scientist at a private biotechnology company and was a post-doctoral fellow at the La Jolla Institute for Allergy and Immunology and UCLA School of Medicine.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Executive career

  1. Current · dates not publishedChief Financial Officer · IDEAYA Biosciences, Inc.
  2. 2026 to end not publishedExecutive title: Chief Financial Officer (Principal Financial Officer) · Organization not publishedIDYA DEF 14A executive officers
  3. Dates not publishedExecutive title: Chief Financial Officer · Organization not publishedIDYA executive roster source

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. IDYA DEF 14A executive officers

    sec filing · Source published: Apr 29, 2026 · Retrieved: May 15, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 15, 2026
    • Executive company: Executive at IDEAYA Biosciences, Inc. · Claim reviewed: May 15, 2026
    • Executive title: Executive title: Chief Financial Officer (Principal Financial Officer) · Claim reviewed: May 15, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 15, 2026

  2. Open source

    sec def 14a · Source published: Apr 29, 2026 · Retrieved: Sep 6, 2026

    Supports 1 claim
    • Professional Role: Chief Financial Officer at IDEAYA Biosciences, Inc. · Claim reviewed: Sep 6, 2026

  3. IDYA executive roster source

    sec filing · Source published: Date unavailable · Retrieved: May 3, 2026

    Supports 5 claims
    • AI expertise: AI expertise: not identified in the cited filing · Claim reviewed: May 3, 2026
    • AI governance relevance: AI governance relevance: not identified in the cited filing · Claim reviewed: May 3, 2026
    • Executive company: Executive at IDEAYA Biosciences, Inc. · Claim reviewed: May 15, 2026
    • Executive function: Finance Controls (CFO) · Claim reviewed: May 3, 2026
    • Executive title: Executive title: Chief Financial Officer · Claim reviewed: May 3, 2026